SELLAS (SLS) is a publicly traded Healthcare sector company. As of September 4, 2026, SLS trades at $13.76 with a market cap of $2.86B and a P/E ratio of -54.56. SLS moved +0.40% today. Year to date, SLS is +214.94%; over the trailing twelve months it is +669.66%. Its 52-week range spans $0.85 to $15.88. Analyst consensus is buy with an average price target of $27.50. Rallies surfaces SLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest SLS news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $13.76 |
| Market Cap | $2.86B |
| P/E Ratio | -54.56 |
| EPS | $-0.25 |
| Dividend Yield | 0.24% |
| 52-Week High | $15.88 |
| 52-Week Low | $0.85 |
| Volume | 49.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.86M |
| Gross Margin | 0.00% |
2 analysts cover SLS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.50.